Cytosorbents Corporation

CTSO | NASDAQ

Price Alert Chart Builder DCF Calculator

$5.47

-$0.04 (-0.73%)

Sep 22, 2026, 12:50 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Revenue	37.06M	35.6M	31.08M	34.69M	40.11M	39.45M
Cost of Revenue	10.57M	10.71M	9.13M	13.96M	11.05M	11.05M
Gross Profit	26.49M	24.89M	21.95M	20.73M	29.06M	28.4M
Operating Income	-14.24M	-16.45M	-31.95M	-31.52M	-22.74M	-10.37M
Interest Income	n/a	n/a	n/a	133K	28K	n/a
Pretax Income	-8.6M	-22.41M	-30.06M	-33.91M	-25.29M	-8.96M
Net Income	-8.2M	-20.72M	-29.25M	-32.81M	-24.56M	-7.84M
Selling & General & Admin	35.65M	33.73M	38.31M	2.79M	38.48M	31.51M
Research & Development	5.09M	7.61M	15.59M	15.12M	16.38M	8.81M
Other Expenses	n/a	n/a	n/a	34.34M	-3.06M	-1.55M
Operating Expenses	40.73M	41.34M	53.9M	52.25M	51.81M	38.77M
Interest Expense	2.61M	1.4M	157.89K	n/a	n/a	1.2M
Selling & Marketing Expenses	n/a	n/a	435.05K	582K	n/a	n/a
Cost & Expenses	51.3M	52.05M	63.03M	66.21M	62.85M	49.82M
Income Tax Expense	-401K	-1.69M	-813.74K	-1.09M	-736K	-1.13M
Shares Outstanding (Basic)	3.11M	2.72M	2.23M	2.18M	2.17M	1.94M
Shares Outstanding (Diluted)	3.11M	2.72M	2.23M	2.18M	2.17M	1.94M
EPS (Basic)	-2.60	-7.60	-13	-15	-11.40	-4
EPS (Diluted)	-2.60	-7.60	-13	-15	-11.40	-4
EBITDA	-4.36M	-19.27M	-27.88M	-30M	-24.17M	-9.71M
EBIT	-5.99M	-21.01M	-29.9M	-30.89M	-25.29M	-10.37M
Depreciation & Amortization	1.63M	1.74M	2.02M	882.62K	1.13M	660.79K